NASDAQ · HURA
TuHURA Biosciences, Inc.
$1.90-$0.16 (-7.54%)
TuHURA Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 44.47% below the high.
Loading market information…
OTC · APTCF · USD
Stock price, earnings
Quote as of May 15, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Advanced Proteome Therapeutics Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Advanced Proteome Therapeutics Corporation, operating through its subsidiary Advanced Proteome Therapeutics Inc., functions as a biotechnology company based in the United States. Its core business involves the creation and commercialization of a unique platform designed for the chemical modification of protein-based treatments. This proprietary technology is applied across several domains, specifically antibody-drug conjugates, broader protein conjugates, and approaches to immunomodulation. The company's corporate base is in Burnaby, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:19 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.90-$0.16 (-7.54%)
TuHURA Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 44.47% below the high.
£6.34-£0.46 (-6.73%)
Hemogenyx Pharmaceuticals Plc’s quoted price sits in the lower half of its reported 52-week range, 48.01% below the high.
$1.86-$0.25 (-12.08%)
Propanc Biopharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.42% below the high.
$0.00+$0.00 (+179,899.98%)
Pivotal Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 14.29% below the high.
$0.01$0.00 (0.0%)
Aladdin Healthcare Technologies SE: Healthcare · Medical - Healthcare Information Services.
$0.00+$0.00 (+9,900.0%)
MedMen Enterprises Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00-$0.00 (-90.0%)
RedHawk Holdings Corp.: Healthcare · Medical - Devices.
$0.03$0.00 (0.0%)
TRACON Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.7% below the high.
